Cladis Investment Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,026
| Closed | -$246K | – | 136 |
|
|
2024
Q3 | $246K | Hold |
6,026
| – | – | 0.17% | 113 |
|
|
2024
Q2 | $232K | Hold |
6,026
| – | – | 0.17% | 119 |
|
|
2024
Q1 | $258K | Hold |
6,026
| – | – | 0.19% | 116 |
|
|
2023
Q4 | $223K | Hold |
6,026
| – | – | 0.18% | 120 |
|
|
2023
Q3 | $218K | Hold |
6,026
| – | – | 0.19% | 115 |
|
|
2023
Q2 | $215K | Buy |
6,026
+66
| +1% | +$2.35K | 0.19% | 122 |
|
|
2023
Q1 | $212K | Hold |
5,960
| – | – | 0.19% | 123 |
|
|
2022
Q4 | $209K | Buy |
+5,960
| New | +$209K | 0.21% | 119 |
|
|
2022
Q3 | – | Sell |
-6,160
| Closed | -$335K | – | 128 |
|
|
2022
Q2 | $335K | Sell |
6,160
-800
| -11% | -$43.5K | 0.33% | 89 |
|
|
2022
Q1 | $379K | Buy |
6,960
+800
| +13% | +$43.6K | 0.31% | 93 |
|
|
2021
Q4 | $340K | Buy |
+6,160
| New | +$340K | 0.27% | 113 |
|